Phytosterol of lotus seed core powder alleviates hypercholesterolemia by regulating gut microbiota in high-cholesterol diet-induced C57BL/6J mice
D Liu, J Pi, B Zhang, H Zeng, C Li, Z Xiao, F Fang… - Food Bioscience, 2023 - Elsevier
The present study aimed to investigate the regulatory mechanisms of lotus seed core
powder phytosterol extract (LSP-PE) on hypercholesterolemia and intestinal microbiota in …
powder phytosterol extract (LSP-PE) on hypercholesterolemia and intestinal microbiota in …
Resistance to cholesterol gallstone disease: hepatic cholesterol metabolism
C Zhang, W Dai, S Yang, S Wu… - The Journal of Clinical …, 2024 - academic.oup.com
Cholesterol gallstone disease (CGD) is one of the most common digestive diseases, and it is
closely associated with hepatic cholesterol metabolism. Cholesterol gallstones may be …
closely associated with hepatic cholesterol metabolism. Cholesterol gallstones may be …
[HTML][HTML] Traditional Chinese medicine for lipid metabolism disorders
Y Li, X Wang, Z Shen - American Journal of Translational Research, 2017 - ncbi.nlm.nih.gov
Dyslipidemia significantly contributes to the development of cardiovascular disease (CVD),
which is the most common cause of morbidity and mortality in China. Statins are the first-line …
which is the most common cause of morbidity and mortality in China. Statins are the first-line …
[HTML][HTML] Novel milk casein–derived peptides decrease cholesterol micellar solubility and cholesterol intestinal absorption in Caco-2 cells
X Jiang, D Pan, T Zhang, C Liu, J Zhang, M Su… - Journal of dairy …, 2020 - Elsevier
This study sought to assess the cholesterol-lowering activity of peptides obtained from milk
casein hydrolyzed with neutrase. The bioactive peptides were separated using a Sephadex …
casein hydrolyzed with neutrase. The bioactive peptides were separated using a Sephadex …
Cranberry anthocyanin as an herbal medicine lowers plasma cholesterol by increasing excretion of fecal sterols
Background Interest in using herbal medicines to treat the hypercholesterolemia is
increasing. Cranberry extract could decrease plasma cholesterol, however, the active …
increasing. Cranberry extract could decrease plasma cholesterol, however, the active …
[HTML][HTML] Hepatic Niemann-Pick C1-Like 1 exacerbates non-alcoholic fatty liver disease by re-absorbing specific biliary oxysterols
Y Yamanashi, T Takada, Y Tanaka, Y Ogata… - Biomedicine & …, 2022 - Elsevier
Background Dietary oxysterols are believed to be associated with the progression of non-
alcoholic fatty liver disease (NAFLD). However, the molecular basis of the association …
alcoholic fatty liver disease (NAFLD). However, the molecular basis of the association …
Plasma cholesterol-lowering activity of dietary dihydrocholesterol in hypercholesterolemia hamsters
X Wang, L Guan, Y Zhao, L Lei, Y Liu, KY Ma, L Wang… - Atherosclerosis, 2015 - Elsevier
Objective Cholesterol analogs have been used to treat hypercholesterolemia. The present
study was to examine the effect of dihydrocholesterol (DC) on plasma total cholesterol (TC) …
study was to examine the effect of dihydrocholesterol (DC) on plasma total cholesterol (TC) …
Future therapeutic targets for the treatment and prevention of cholesterol gallstones
IG Castro-Torres… - European Journal of …, 2015 - Elsevier
The formation of cholesterol gallstones involves very complex imbalances, such as
alterations in the secretion of biliary lipids (which involves the ABCG5, ABCG8, ABCB4 and …
alterations in the secretion of biliary lipids (which involves the ABCG5, ABCG8, ABCB4 and …
Fisiopatología de cálculos biliares de colesterol: la búsqueda de una diana terapéutica
IG Castro-Torres, IB Bermúdez-Camps - Revista Biomedica, 2015 - revistabiomedica.mx
En la fisiopatología de los cálculos biliares de colesterol se involucran diferentes desajustes
tales como, la alteración en la secreción de lípidos biliares, la cristalización o nucleación del …
tales como, la alteración en la secreción de lípidos biliares, la cristalización o nucleación del …
以NPC1L1 为靶点治疗胆固醇结石的研究进展
陈露露, 周宏灏, 欧阳冬生 - 中国临床药理学与治疗学, 2015 - manu41.magtech.com.cn
胆固醇结石病因形成复杂, 涉及到胆汁脂类分泌的改变, 胆固醇结晶, 胆囊组织中的重要免疫反应
, 粘蛋白的形成以及胆囊动力不足等多个方面. 抑制肠道对胆固醇的吸收, 减少胆汁分泌是胆固醇 …
, 粘蛋白的形成以及胆囊动力不足等多个方面. 抑制肠道对胆固醇的吸收, 减少胆汁分泌是胆固醇 …